Welcome to Novo Nordisk Science Hub
The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Prof. Lise L Gluud is a consultant Gastroenterologist and Professor of gastroenterology and hepatology, a member of the steering committee at Centre for Liver Disease in Copenhagen (CLIC) and the Centre for Obesity at Amager and Hvidovre Hospital. Her main research areas include lifestyle associated liver diseases focusing on non-alcoholic steatohepatitis as well as cirrhosis-related complications and clinical as well as pathophysiological studies with 162 Medline Indexed publications and a H index of 66. Other interest areas include inflammatory and metabolic complications associated with pancreatitis. She has Qualifications include: Specially Appointed Named Person at the Faculty of Health and Medical Sciences, University of Copenhagen, Member of the National Committee on Health Research Ethics; Chairman of the National Clinical Guideline for the Management of patients with NAFLD; Chairman of the Danish Association of Gastroenterology and Hepatology (DSGH) Research Committee; Plos ONE Section Editor; and Editor Cochrane Hepato-Biliary Group.
A.G. Onno Holleboom
Amsterdam UMC, Amsterdam, Netherlands
Dr. A.G. (Onno) Holleboom MD PhD is an internist registered in Vascular Medicine and Endocrinology, faculty member of the Department of Vascular Medicine and Assistant Professor at Amsterdam UMC. He heads a multidisciplinary outpatient clinic for NAFLD together with hepatology and including clinical trials. Within the NAFLD-NL consortium and supported by the Dutch MLDS gastroenterology and hepatology foundation, his team investigates and implements care paths for NAFLD together with LUMC and Radboud MC. He participates in LITMUS, will participate in the new Grip on NASH consortium, has co-authored the Dutch NAFLD-NASH guideline and is on the Delphi panel for the revised EASL-EASD-EASO guideline. Together with prof. Max Nieuwdorp, he runs a research group with 5 PhD candidates focussing on genetic and gut microbial drivers of NAFLD in three cohort studies, as well as more fundamental work on pathways around lipophagy and liver sinusoidal endothelium. He has published 73 peer-reviewed articles, including in Circulation and Cell Metabolism and received various prestigious grants, a.o. from The Netherlands Organization for Scientific Research and the Amsterdam UMC Fellowship.
Read full bio